10/31/14 LH 109.29 Laboratory Corporation of Ameri
Post# of 50
Posted On: 11/02/2014 1:00:40 AM
10/31/14 LH 109.29 Laboratory Corporation of America Holdin $LH Hit a 52 week high of 109.47 Closing the day 10/31/14 at 109.29 +1.90 +1.77% With a day low of 108.24 and a total volume of 901,200.
LH Recent Posts: http://investorshangout.com/Laboratory-Corpor...-LH-51679/
LH Laboratory Corporation of America Holdin Recent Headline News
Laboratory Corp of America: Steps in the Right Direction?
Todd Campbell, The Motley Fool - Motley Fool - Tue Oct 28, 4:44PM CDT
Source: LabCorp Laboratory Corp of America is the nation's second largest healthcare lab services company, yet it owns just 10% of the $60 billion market for its services in the United States. That suggests that there's a significant...
LH: 109.29 (+1.90)
Laboratory Corp. of America (LH) Higher After Earnings Beat
at The Street - Tue Oct 28, 3:05PM CDT
Laboratory Corp. of America (LH) shares closed trading up after the company beat analysts earnings expectations and raised its revenue growth guidance for the year.
LH: 109.29 (+1.90)
LabCorp Outshines Earnings, Revenues in Q3; Guides Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:30PM CDT
Laboratory Corporation of America Holdings (LH) reported third-quarter 2014 adjusted earnings per share (EPS) of $1.80.
CAH: 78.48 (+0.29), DGX: 63.46 (-0.02), LH: 109.29 (+1.90), HSIC: 120.03 (-0.18)
Laboratory Corporation Of America (LH) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Tue Oct 28, 12:22PM CDT
The following Laboratory Corporation of America (LH) conference call took place on October 28, 2014, 09:00 AM ET. This is a transcript of that earnings call:
LH: 109.29 (+1.90)
Laboratory Corporation of America(R) Holdings Announces 2014 Third Quarter Results and Increases 2014 EPS Guidance
Business Wire - Tue Oct 28, 5:45AM CDT
--Diluted EPS of $1.59; Adjusted EPS of $1.80
LH: 109.29 (+1.90)
Is LabCorp (LH) Likely to Disappoint Earnings in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 2:20PM CDT
Laboratory Corp. of America Holdings (LH) is scheduled to release its third-quarter 2014 results before the opening bell on Oct 28.
LH: 109.29 (+1.90), HTWR: 77.12 (+0.98), HOLX: 26.19 (+0.27), HSP: 53.70 (-0.54)
LabCorp Introduces HIV-1 Next Generation Sequencing Assay to Support Drug Regimen Changes in HIV Suppressed Patients
Business Wire - Mon Oct 20, 7:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) and Monogram Biosciences, Inc., part of the LabCorp Specialty Testing Group, today announced the launch of HIV GenoSure Archive(SM), the first laboratory test to help optimize antiretroviral (ARV) drug regimens in virally suppressed HIV patients. GenoSure Archive was developed using the Next Generation Sequencing (NGS) platform.
LH: 109.29 (+1.90)
LipoScience announces Antitrust Approval for pending acquisition by LabCorp
M2 - Thu Oct 16, 10:00AM CDT
Diagnostic tests company LipoScience (NasdaqGM:LPDX) reported on Wednesday that it has received the Federal Trade Commission's early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 applicable to its acquisition by Laboratory Corporation of America Holdings (LabCorp) (NYSE:LH).
LPDX: 5.22 (+0.01), LH: 109.29 (+1.90)
LabCorp's Acquisition of LipoScience Clears Antitrust Approval
Business Wire - Wed Oct 15, 6:15PM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 applicable to the acquisition of LipoScience, Inc. (NASDAQ: LPDX) by LabCorp.
LPDX: 5.22 (+0.01), LH: 109.29 (+1.90)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of LipoScience, Inc. in Connection with the Sale of the Company
Business Wire - Tue Oct 14, 5:32PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of LipoScience, Inc. ("LipoScience" or the "Company"
(Nasdaq: LPDX) relating to the proposed acquisition by Laboratory Corporation of America Holdings ("LH" .
LPDX: 5.22 (+0.01), LH: 109.29 (+1.90)
Cardinal Health and Ohio State Open Pharma Center - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 3:44PM CDT
The molecular imaging pharmaceuticals center will combine Ohio State's Wright Center of Innovation in Biomedical Imaging's research capabilities with Cardinal Health's (CAH) developmental, manufacturing and commercialization expertise
CAH: 78.48 (+0.29), LH: 109.29 (+1.90), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
Illumina Pads Gene Sequencing Lead With Pharma Deals
at Investor's Business Daily - Wed Oct 08, 3:04PM CDT
When you become the 800-pound gorilla in your industry, you don't suddenly decide that 800 pounds is enough. Instead, you start looking for ways to reach 900 pounds, or 1,000, or some weight that breaks the scales altogether. In the market for...
DGX: 63.46 (-0.02), AZN: 72.94 (+0.34), LH: 109.29 (+1.90), AMGN: 162.18 (+0.60), ILMN: 192.58 (-0.84), SNY: 46.24 (+0.54)
Becton, Dickinson (BDX) Jumps: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 8:46AM CDT
Becton, Dickinson (BDX) was a big mover last session, with shares rising nearly 8% on the day.
BDX: 128.70 (+1.18), CAH: 78.48 (+0.29), LH: 109.29 (+1.90), COO: 163.90 (+0.24)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of LipoScience, Inc. in Connection with the Sale of the Company -LPDX
PR Newswire - Sat Oct 04, 6:05AM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of LipoScience, Inc. ("LipoScience" or the "Company" (Nasdaq -LPDX-News) relating to the proposed acquisition by Laboratory Corporation of America Holdings. ("LH" .
LPDX: 5.22 (+0.01), LH: 109.29 (+1.90)
Align Adds DENTSPLY Implants Digital Workflow to Scanner - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 1:50PM CDT
Align Technology, Inc. (ALGN) expanded digital workflow options for the iTero Intraoral Scanner.
ABC: 85.41 (+0.57), MCK: 203.41 (-0.07), ALGN: 52.62 (+0.67), LH: 109.29 (+1.90)
Align's Product Enhancement Continues amid Economy Woes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 1:50PM CDT
On Sep 26, 2014, we issued an updated research report on Align Technology Inc. (ALGN).
ABC: 85.41 (+0.57), MCK: 203.41 (-0.07), ALGN: 52.62 (+0.67), LH: 109.29 (+1.90)
Cardinal Health Unit and KEW Group Unite to Treat Cancer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 12:10PM CDT
Cardinal Health Inc.'s (CAH) community oncologists will enjoy access to KEW's advanced diagnostics tools, enabling them to provide personalized medicine treatments.
MCK: 203.41 (-0.07), CAH: 78.48 (+0.29), LH: 109.29 (+1.90), COO: 163.90 (+0.24)
LabCorp (LH) to Acquire LipoScience: A Strategic Fit? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 01, 1:50PM CDT
Laboratory Corporation of America Holdings (LH) has decided to acquire LipoScience, Inc. (LPDX) for $5.25 per share.
ABC: 85.41 (+0.57), LPDX: 5.22 (+0.01), MCK: 203.41 (-0.07), LH: 109.29 (+1.90)
LH Recent Posts: http://investorshangout.com/Laboratory-Corpor...-LH-51679/
LH Laboratory Corporation of America Holdin Recent Headline News
Laboratory Corp of America: Steps in the Right Direction?
Todd Campbell, The Motley Fool - Motley Fool - Tue Oct 28, 4:44PM CDT
Source: LabCorp Laboratory Corp of America is the nation's second largest healthcare lab services company, yet it owns just 10% of the $60 billion market for its services in the United States. That suggests that there's a significant...
LH: 109.29 (+1.90)
Laboratory Corp. of America (LH) Higher After Earnings Beat
at The Street - Tue Oct 28, 3:05PM CDT
Laboratory Corp. of America (LH) shares closed trading up after the company beat analysts earnings expectations and raised its revenue growth guidance for the year.
LH: 109.29 (+1.90)
LabCorp Outshines Earnings, Revenues in Q3; Guides Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:30PM CDT
Laboratory Corporation of America Holdings (LH) reported third-quarter 2014 adjusted earnings per share (EPS) of $1.80.
CAH: 78.48 (+0.29), DGX: 63.46 (-0.02), LH: 109.29 (+1.90), HSIC: 120.03 (-0.18)
Laboratory Corporation Of America (LH) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Tue Oct 28, 12:22PM CDT
The following Laboratory Corporation of America (LH) conference call took place on October 28, 2014, 09:00 AM ET. This is a transcript of that earnings call:
LH: 109.29 (+1.90)
Laboratory Corporation of America(R) Holdings Announces 2014 Third Quarter Results and Increases 2014 EPS Guidance
Business Wire - Tue Oct 28, 5:45AM CDT
--Diluted EPS of $1.59; Adjusted EPS of $1.80
LH: 109.29 (+1.90)
Is LabCorp (LH) Likely to Disappoint Earnings in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 2:20PM CDT
Laboratory Corp. of America Holdings (LH) is scheduled to release its third-quarter 2014 results before the opening bell on Oct 28.
LH: 109.29 (+1.90), HTWR: 77.12 (+0.98), HOLX: 26.19 (+0.27), HSP: 53.70 (-0.54)
LabCorp Introduces HIV-1 Next Generation Sequencing Assay to Support Drug Regimen Changes in HIV Suppressed Patients
Business Wire - Mon Oct 20, 7:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) and Monogram Biosciences, Inc., part of the LabCorp Specialty Testing Group, today announced the launch of HIV GenoSure Archive(SM), the first laboratory test to help optimize antiretroviral (ARV) drug regimens in virally suppressed HIV patients. GenoSure Archive was developed using the Next Generation Sequencing (NGS) platform.
LH: 109.29 (+1.90)
LipoScience announces Antitrust Approval for pending acquisition by LabCorp
M2 - Thu Oct 16, 10:00AM CDT
Diagnostic tests company LipoScience (NasdaqGM:LPDX) reported on Wednesday that it has received the Federal Trade Commission's early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 applicable to its acquisition by Laboratory Corporation of America Holdings (LabCorp) (NYSE:LH).
LPDX: 5.22 (+0.01), LH: 109.29 (+1.90)
LabCorp's Acquisition of LipoScience Clears Antitrust Approval
Business Wire - Wed Oct 15, 6:15PM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 applicable to the acquisition of LipoScience, Inc. (NASDAQ: LPDX) by LabCorp.
LPDX: 5.22 (+0.01), LH: 109.29 (+1.90)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of LipoScience, Inc. in Connection with the Sale of the Company
Business Wire - Tue Oct 14, 5:32PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of LipoScience, Inc. ("LipoScience" or the "Company"
(Nasdaq: LPDX) relating to the proposed acquisition by Laboratory Corporation of America Holdings ("LH" . LPDX: 5.22 (+0.01), LH: 109.29 (+1.90)
Cardinal Health and Ohio State Open Pharma Center - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 3:44PM CDT
The molecular imaging pharmaceuticals center will combine Ohio State's Wright Center of Innovation in Biomedical Imaging's research capabilities with Cardinal Health's (CAH) developmental, manufacturing and commercialization expertise
CAH: 78.48 (+0.29), LH: 109.29 (+1.90), XRAY: 50.77 (+0.68), COO: 163.90 (+0.24)
Illumina Pads Gene Sequencing Lead With Pharma Deals
at Investor's Business Daily - Wed Oct 08, 3:04PM CDT
When you become the 800-pound gorilla in your industry, you don't suddenly decide that 800 pounds is enough. Instead, you start looking for ways to reach 900 pounds, or 1,000, or some weight that breaks the scales altogether. In the market for...
DGX: 63.46 (-0.02), AZN: 72.94 (+0.34), LH: 109.29 (+1.90), AMGN: 162.18 (+0.60), ILMN: 192.58 (-0.84), SNY: 46.24 (+0.54)
Becton, Dickinson (BDX) Jumps: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 8:46AM CDT
Becton, Dickinson (BDX) was a big mover last session, with shares rising nearly 8% on the day.
BDX: 128.70 (+1.18), CAH: 78.48 (+0.29), LH: 109.29 (+1.90), COO: 163.90 (+0.24)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of LipoScience, Inc. in Connection with the Sale of the Company -LPDX
PR Newswire - Sat Oct 04, 6:05AM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of LipoScience, Inc. ("LipoScience" or the "Company"
(Nasdaq -LPDX-News) relating to the proposed acquisition by Laboratory Corporation of America Holdings. ("LH" . LPDX: 5.22 (+0.01), LH: 109.29 (+1.90)
Align Adds DENTSPLY Implants Digital Workflow to Scanner - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 1:50PM CDT
Align Technology, Inc. (ALGN) expanded digital workflow options for the iTero Intraoral Scanner.
ABC: 85.41 (+0.57), MCK: 203.41 (-0.07), ALGN: 52.62 (+0.67), LH: 109.29 (+1.90)
Align's Product Enhancement Continues amid Economy Woes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 1:50PM CDT
On Sep 26, 2014, we issued an updated research report on Align Technology Inc. (ALGN).
ABC: 85.41 (+0.57), MCK: 203.41 (-0.07), ALGN: 52.62 (+0.67), LH: 109.29 (+1.90)
Cardinal Health Unit and KEW Group Unite to Treat Cancer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 12:10PM CDT
Cardinal Health Inc.'s (CAH) community oncologists will enjoy access to KEW's advanced diagnostics tools, enabling them to provide personalized medicine treatments.
MCK: 203.41 (-0.07), CAH: 78.48 (+0.29), LH: 109.29 (+1.90), COO: 163.90 (+0.24)
LabCorp (LH) to Acquire LipoScience: A Strategic Fit? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 01, 1:50PM CDT
Laboratory Corporation of America Holdings (LH) has decided to acquire LipoScience, Inc. (LPDX) for $5.25 per share.
ABC: 85.41 (+0.57), LPDX: 5.22 (+0.01), MCK: 203.41 (-0.07), LH: 109.29 (+1.90)
(0)
(0)Laboratory Corporation Of America Holdings (LH) Stock Research Links
Scroll down for more posts ▼